Burcon NutraScience Corporation
BRCNFOTCConsumer Defensive● Active
$1.39
+$0.07(+5.30%)
Market Cap$17642264
P/E Ratio—
52W High$3.57
52W Low$1.1437
Burcon NutraScience Corporation (BRCNF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
BRCNF · earnings · updated Jun 8, 2026
Latest Earnings
Q1 FY2026Report Date: Feb 11, 2026EPS Actual
-$0.20
Est. -$0.03 · -603.7%
Revenue
$0.00B
Est. $0.00B · -26.1%
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Feb 11, 2026
After Market Close
▼ Miss EPS▼ Miss Revenue
BRCNF reports quarterly as a OTC-listed Packaged Foods company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.21
Rev. $0.66B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.21
Rev. Est.$0.66B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 1, 2026 | -$0.07 | — | — | — | $0.00B | — |
| ◌ Q2 FY2026 | Jun 24, 2026 | -$0.07 | — | — | — | $0.00B | — |
| ▼ Q1 FY2026 | Feb 11, 2026 | -$0.03 | -$0.20 | -603.7% | $0.00B | $0.00B | -26.1% |
| ▼ Q4 FY2025 | Nov 12, 2025 | -$0.04 | -$0.21 | -485.0% | $0.00B | $0.00B | -64.0% |
| ▼ Q3 FY2025 | Aug 13, 2025 | -$0.05 | -$0.20 | -289.0% | $0.00B | $0.00B | -61.5% |
| — Q2 FY2025 | Jun 25, 2025 | — | -$0.16 | — | $0.00B | $0.00B | -95.4% |
| ▼ Q1 FY2025 | Feb 14, 2025 | -$0.11 | -$0.20 | -74.0% | $0.00B | $0.00B | -93.3% |
| ▼ Q4 FY2024 | Nov 14, 2024 | -$0.12 | -$0.20 | -63.6% | $0.00B | $0.00B | -93.0% |
Q3 FY2026
Jul 1, 2026
EPS Actual
—
EPS Est.
-$0.07
EPS Surpr.
—
Revenue
—
Q2 FY2026
Jun 24, 2026
EPS Actual
—
EPS Est.
-$0.07
EPS Surpr.
—
Revenue
—
Q1 FY2026
Feb 11, 2026Miss
EPS Actual
-$0.20
EPS Est.
-$0.03
EPS Surpr.
-603.7%
Revenue
$0.00B
Q4 FY2025
Nov 12, 2025Miss
EPS Actual
-$0.21
EPS Est.
-$0.04
EPS Surpr.
-485.0%
Revenue
$0.00B
Q3 FY2025
Aug 13, 2025Miss
EPS Actual
-$0.20
EPS Est.
-$0.05
EPS Surpr.
-289.0%
Revenue
$0.00B
Q2 FY2025
Jun 25, 2025
EPS Actual
-$0.16
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2025
Feb 14, 2025Miss
EPS Actual
-$0.20
EPS Est.
-$0.11
EPS Surpr.
-74.0%
Revenue
$0.00B
Q4 FY2024
Nov 14, 2024Miss
EPS Actual
-$0.20
EPS Est.
-$0.12
EPS Surpr.
-63.6%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2028 | $0.13 | $0.13 | $0.13 | 1 |
| Q4 FY2027 | $0.11 | $0.11 | $0.11 | 1 |
| Q3 FY2027 | $0.08 | $0.08 | $0.08 | 1 |
| Q2 FY2027 | $0.04 | $0.04 | $0.04 | 1 |
| Q1 FY2027 | $0.02 | $0.02 | $0.02 | 1 |
| Q4 FY2026 | $-0.03 | $-0.03 | $-0.03 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q1 FY2026 | Feb 11, 2026 | -603.7% | $1.37 | $1.33 | -2.92% |
| ▼ Q4 FY2025 | Nov 12, 2025 | -485.0% | $1.70 | $1.70 | +0.00% |
| ▼ Q3 FY2025 | Aug 13, 2025 | -289.0% | $1.99 | $1.99 | +0.00% |
| — Q2 FY2025 | Jun 25, 2025 | — | $3.33 | $3.23 | -3.00% |
| ▼ Q1 FY2025 | Feb 14, 2025 | -74.0% | $1.39 | $1.38 | -0.72% |
| ▼ Q4 FY2024 | Nov 14, 2024 | -63.6% | $1.82 | $1.88 | +3.30% |
| ▲ Q3 FY2024 | Aug 14, 2024 | +14.1% | $3.12 | $3.12 | +0.00% |
| ▲ Q2 FY2024 | Jun 26, 2024 | +39.7% | $3.90 | $3.30 | -15.38% |
Q1 FY2026-2.92%
Report Date
Feb 11, 2026
EPS Beat/Miss
-603.7%
Price Before
$1.37
Price After
$1.33
Q4 FY2025+0.00%
Report Date
Nov 12, 2025
EPS Beat/Miss
-485.0%
Price Before
$1.70
Price After
$1.70
Q3 FY2025+0.00%
Report Date
Aug 13, 2025
EPS Beat/Miss
-289.0%
Price Before
$1.99
Price After
$1.99
Q2 FY2025-3.00%
Report Date
Jun 25, 2025
EPS Beat/Miss
—
Price Before
$3.33
Price After
$3.23
Q1 FY2025-0.72%
Report Date
Feb 14, 2025
EPS Beat/Miss
-74.0%
Price Before
$1.39
Price After
$1.38
Q4 FY2024+3.30%
Report Date
Nov 14, 2024
EPS Beat/Miss
-63.6%
Price Before
$1.82
Price After
$1.88
Q3 FY2024+0.00%
Report Date
Aug 14, 2024
EPS Beat/Miss
+14.1%
Price Before
$3.12
Price After
$3.12
Q2 FY2024-15.38%
Report Date
Jun 26, 2024
EPS Beat/Miss
+39.7%
Price Before
$3.90
Price After
$3.30
Avg Beat Reaction-7.69%
Avg Miss Reaction-0.07%
Beat Rate2 / 8 quarters
Largest Move-15.38% (Q2 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: BRCNF ends December
Burcon NutraScience Corporation (BRCNF) most recently reported earnings on February 11, 2026 for Q1 FY2026, posting EPS of $-0.20 — missing the analyst consensus of $-0.03 by -603.7%. The next BRCNF earnings date is expected around September 1, 2026.
Each quarter, investors track BRCNF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BRCNF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
BRCNF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
BRCNF earnings · 5 questionsBurcon NutraScience Corporation's next earnings report is expected around September 1, 2026. BRCNF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BRCNF historically reports after market close (AMC).
BRCNF earnings datewhen is BRCNF earningsBRCNF next earnings datewhen does BRCNF report earningsBRCNF earnings calendar
▸ Source: FMP · Burcon NutraScience Corporation SEC filings · US GAAP · Burcon NutraScience Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026